Back

Five-year outcomes after first- or second-generation drug-eluting stent implantation in all-comer patients undergoing percutaneous coronary intervention

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - PCI - Restenosis Restenosis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Hideki Yano

Ohtawara Redcross Hospital, Odawara (Japan)

11 More presentations in this session

Presentation thumbnail
Impact of the J-CTO score on long-term target lesion revascularization rate after native chronic total coronary occlusion angioplasty
Doctor M. Abe (Kyoto, JP)
Abstract
Presentation thumbnail
Contribution of post-stent irregular protrusion to in-stent neoatheroscrelosis after second-generation drug-eluting stent implantation. - Optical coherence tomography study-
Doctor Y. Sanuki (Kitakyusyu, JP)
Abstract Slides
Presentation thumbnail
Impact of chronic kidney disease on stent strut coverage and neointimal tissue characteristics as assessed by optical coherence tomography
Miss Y. Wang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Predictors of target lesion revascularization after paclitaxel-coated balloon treatment of in-stent restenosis: a real-world single center registry.
Doctor I. Bossi (Milano, IT)
Abstract Slides
Presentation thumbnail
Clinical impact of immediate residual stenosis on clinical outcomes after deploying everolimus-eluting stent and biolimus-eluting stents: insights from a pooled analysis of RESET and NEXT trial.
Mr H. Watanabe (Wakayama, JP)

Access the full session

Session thumbnail
Poster session 1 - PCI - Restenosis

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources